Study: Low-FODMAP diet may reduce abdominal pain in pediatric IBS | Aging GI tract muscles, pain drugs may lead to constipation, dietitian says | Use of low-dose aspirin, NSAIDs linked to reduced colon cancer risk
August 28, 2015
CONNECT WITH ACG®  FacebookTwitter
Digestive Health SmartBrief
From Stanley K. Fergus and the American College of Gastroenterology

Top StoryAdvertisement
Study: Low-FODMAP diet may reduce abdominal pain in pediatric IBS
Researchers found a low-FODMAP diet led to fewer abdominal pain episodes per day in children with irritable bowel syndrome, compared with a typical American diet. Data also showed children who responded to a low fermentable oligosaccharides, disaccharides, monosaccharides and polylols diet had different baseline microbiome composition than those who did not respond to the diet. Healio (free registration)/Gastroenterology (8/25)
Share: LinkedInTwitterFacebookGoogle+Email
How well do you know Adaptive Web Design?
Retailers of all sizes are now realizing what giants like Amazon have known for years: that the ultimate mobile web solution blends the best of all available methods into an adaptive approach. In this whitepaper, we answer:
• What is adaptive web design?
• How does it compare to other solutions in cost, effort, and business impact?
• How do I know if an adaptive approach is right for my business?
• What steps can I take to start down this path?
Access it now!

Guide to Healthy LivingAdvertisement
Aging GI tract muscles, pain drugs may lead to constipation, dietitian says
Aging can slow muscular function, including that of the gastrointestinal tract, and when combined with some medications can slow the body's digestive pipeline and lead to constipation, said registered dietitian Anita Miles Curpier. Older adults with chronic conditions may take multiple medications, including pain relievers, that are linked to constipation and other GI problems. The Courier-Journal (Louisville, Ky.) (tiered subscription model) (8/25)
Share: LinkedInTwitterFacebookGoogle+Email
Use of low-dose aspirin, NSAIDs linked to reduced colon cancer risk
People who regularly took low-dose aspirin for five years or more had a 27% lower risk of colon cancer, while those taking other nonsteroidal anti-inflammatory drugs reduced their risk from 30% to 45%, according to research published in the Annals of Internal Medicine. The drugs were used on a regular basis for years before any cancer prevention benefits were attained, said Dr. John Baron of the University of North Carolina at Chapel Hill. "For aspirin, you would have to take it fairly consistently, meaning at least every other day, for at least five to 10 years for the protective effect to even begin to appear," said Baron, co-author of the study. He said NSAIDs have potential risks and patients should not use them for cancer prevention without consulting their physician. HealthDay News (8/24)
Share: LinkedInTwitterFacebookGoogle+Email
Doctors: Give foods containing peanuts to infants with allergy risk
Infants at high risk of peanut allergies should be given foods that contain peanuts before they reach age 1, but they must first undergo allergy tests before being given such foods, according to a recommendation from the American Academy of Pediatrics. The guidance is in response to a British study, which showed that at-risk children who ate peanut products as infants experienced 81% fewer peanut allergies after five years than those who didn't. CBS News/The Associated Press (8/25)
Share: LinkedInTwitterFacebookGoogle+Email
Are you sharing files the wrong way?
Read this free infographic to see the negative side of not caring how your company sends files. Learn how to share better with others so that you can easily:
• Know file-size restrictions for email and the limitations of FTP.
• Avoid freemium services that put you at risk for data breaches.
• Discover the best way to share data and store it securely in one place.
Download the free infographic now.

Diagnosis & Treatment
Studies fail to show when IBD patients can stop anti-TNF therapy
Spanish researchers said there is not sufficient data to determine when patients with inflammatory bowel disease who achieve remission should stop anti-tumor necrosis factor therapy. A data analysis found about a third of IBD patients who stop treatment have a relapse one year later, but researchers said the studies were not strong enough to make recommendations and stopping treatment should be an individualized decision. Healio (free registration)/Gastroenterology (8/25)
Share: LinkedInTwitterFacebookGoogle+Email
Study: Travel distance affects rates of obtaining preventive chemotherapy for colon cancer
Long travel times may reduce the number of colorectal cancer patients who get adjuvant chemotherapy to prevent a recurrence of the disease, American Cancer Society researchers reported. Experts said patients may not be able to take time off from work or are unable to drive themselves home after treatment. Reuters (8/24)
Share: LinkedInTwitterFacebookGoogle+Email
Policy Watch
Health experts: Ease or cut restrictions on hepatitis C drugs for Medicaid patients
Experts from the Presidential Advisory Council on HIV/AIDS and the Public Health Service are asking federal and state Medicaid officials to eliminate or relax the restrictions on patient access to hepatitis C treatments because the rules can result in denying or delaying treatment for some Medicaid members. In a letter sent to President Barack Obama, council members called the restrictions "unreasonable and discriminatory." The council also said drugmakers should be transparent about costs associated with development and manufacturing of the treatments. The New York Times (free-article access for SmartBrief readers) (8/25)
Share: LinkedInTwitterFacebookGoogle+Email
CBO predicts rise in federal spending on health care
Federal spending on health insurance exchange subsidies, Medicare, Medicaid and the Children's Health Insurance Program will rise by $272 billion from 2016 to 2025, representing an estimated 6.2% of the nation's gross domestic product, the Congressional Budget Office says. Subsidies for health insurance purchased through publicly run exchanges will cost $16 billion less than previously projected as more people get coverage through CHIP or Medicaid, the CBO said. Modern Healthcare (tiered subscription model) (8/25)
Share: LinkedInTwitterFacebookGoogle+Email
FDA study finds drug ad corrections ineffective
Direct-to-consumer drug ads that correct misleading or omitted information shown in another ad do little to change viewers' perceptions about risks, an FDA study found. Modern Healthcare (tiered subscription model) (8/25)
Share: LinkedInTwitterFacebookGoogle+Email
Patient's Perspective
Back to school with celiac disease
"It is that time of the year, again. That time when most moms and dads are thinking of school supplies, uniforms, bus rides, teachers, classmates, lunch menus and, in three words, everything related to 'Back to school'. For me, my husband, our daughter and all the families out there with children with CD these three words have another meaning: FEAR. It’s that time of the year when we wake up in the middle of the night thinking: will our daughter’s 3rd grade teacher understand the meaning of CD? Will she/he be supportive and understanding? Will she/he talk about allergies and diseases with her/his class? Will she/he notice when and if our daughter gets glutened?" -- blog post on
Share: LinkedInTwitterFacebookGoogle+Email
The Last Word
News and information from the American College of Gastroenterology
Gallstone disease: Are you at risk?
Gallstones are one of the most common gastrointestinal problems, especially for women. Women between the ages of 20 and 60 years are three times more likely to develop gallstones than men. Learn more about the symptoms and risk factors for developing gallstone disease.
Share: LinkedInTwitterFacebookGoogle+Email
The harder the conflict, the more glorious the triumph."
-- Thomas Paine,
political theorist and revolutionary
Share: LinkedInTwitterFacebookGoogle+Email
Contact Your Doctor
Stanley K. Fergus
Gastroenterolgy Associates of West Tennessee
1400 Kings Boulevard
Memphis, TN 38105

Phone: (901) 555-1234
Contact ACG
American College of Gastroenterology
P.O. Box 342260
Bethesda, MD 20827-2260
The presence of any advertisement in this newsletter does not constitute endorsement of the associated service, product, or company by the American College of Gastroenterology, SmartBrief, or any participating physicians.
The information contained in Digestive Health SmartBrief is not intended to be medical advice. Consult your physician before making any decisions regarding your health care.
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
Advertising:  Rebecca Adelson
  P: 202.618.5665
Editor:  Tara Rosenzweig

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2015 SmartBrief, Inc.®
Privacy policy |  Legal Information